SEC Form 4 · accession 0001171843-15-004868
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter P. Pfreundschuh
Officer — Chief Financial Officer
Period of report
Aug 20, 2015
Accepted (ET)
Aug 24, 2015 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2015 | A | 15,341 | $0.00 | A | 29,706 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $1.76 | Aug 20, 2015 | A | 38,484 | A | — | Aug 20, 2022 | Common Stock, par value $0.01 per share | 38,484 | 38,484 | D |
Explanation of responses
- F1Such restricted stock units were granted pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
- F2The reporting person was granted stock options pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.